Senate Boost To US FDA Device Spending Falls Short of House's Bid
Executive Summary
The Senate would provide US FDA’s device program with a slight 2.2% boost in 2019 spending, to $299.99m, under numbers approved by the Senate Appropriations Committee May 24. But device activities ultimately could see a lot more next fiscal year, as the House is seeking $368.24m.
You may also be interested in...
Trump Signs 2019 US Federal Funding Bill, Stopping Another FDA Shutdown; CDRH Sees $69M Boost
US FDA’s device center gained a total of $471.4m in budget authority, plus more than $200m that Congress authorized in user-fee funding for the current fiscal year, in a 2019 federal agency spending package signed into law Feb. 15 by the president that prevented a second agency shutdown. The $471.4m budget is roughly $69m more than was given to CDRH for FY 2018.
House Panel Approves Boosts For FDA Digital Health Plan, Quality Medtech Manufacturing
The US House Appropriations Committee in 2019 wants to give FDA an additional $40m to boost its digital health oversight, $12m more to “create a competitive marketplace for device quality,” and instructs the agency to keep working with Congress on a new laboratory-developed test regulatory path.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.